Supplementary Materials for Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study

Published: 30 January 2026| Version 1 | DOI: 10.17632/35hcbr3nnz.1
Contributors:
Eliza Dewey,
,
,
,
,

Description

Supplementary materials for the manuscript "Safety and tolerability of combination oral spironolactone and low-dose oral minoxidil for hair loss in adult females: A retrospective cohort study" include tables and figures outlining combination treatment medication dosing (e.g., initial, max, ADE-associated doses of spironolactone and oral minoxidil), patient-reported reasons for therapeutic discontinuation, frequency of adverse effects attributed to medications within the combination regimen, ADE risk factor regression analysis, and cohort selection.

Files

Institutions

  • Brigham and Women's Hospital Department of Dermatology
    MA, Boston

Categories

General Dermatology, Alopecia, Combination Therapy, Drug Safety, Drug Tolerability, Hair Loss

Licence